Cancer

August 27, 2017

Natural product-derived therapy for Metastatic human tumors: A therapeutic mix encompassing Ivermectin and Curcumin  decreases the expression of c-SRC protein, inhibits the expression of a number of enzymes of glycolysis, and suppresses proliferation, migration, invasion, tumorigenesis and metastasis via up regulation of its target gene, 28/August/2017, 12.31 am

Introduction: What they say: A study from the State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen […]
August 27, 2017

Natural product-derived therapy for Acute Myeloid Leukemia: A therapeutic mix encompassing Ivermectin and Curcumin  decreases the expression of BCLAF1,  promotes differentiation of acute myeloid leukemic cells, restores treatment responsiveness, increases therapeutic index of anticancer drugs, and promotes regression of AML via up-regulation of its target gene, 28/August/2017, 12.23 am

Introduction: What they say: A study from the Institute of Genetics and Biophysics, CNR, Naples, Italy; and Department of Biochemistry, Biophysics and General Pathology, Second University […]
August 27, 2017

Molecular therapy for Metastatic cancers: Myrtenal, isolated  from Taxus, increases the expression of metastasis/tumor suppressors  BTG2 and INK4a, inhibits cell cycle progression, and suppresses migration, invasion and metastasis of cancer cells via up regulation of its target gene, 27/August/2017, 8.25 am

From Significance of the study to Public health relevance: Given that: (i) each year nearly 14 million people are diagnosed with cancer globally, and little more […]
August 26, 2017

Natural product-derived therapy for gynecologic cancers: A therapeutic mix encompassing  Berberine (BER), Dihydroartemisinin (DHA), and Curcumin (CUR)inhibits the expression of HDAC6, acetylates tumor suppressor proteins, activates tumor suppressor function, and stifles the progression of ARID1A-mutated ovarian cancers via up-regulation of its target gene, 26/August/2017, 11.59 pm

Introduction: What they say: A study from Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA shows that “ARID1A-mutated ovarian cancers depend on […]